Quince Therapeutics, Inc. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2021-08-26: Study NCT04920903; Company role Lead sponsor; Phase Phase 1; Status Completed.
- 2019-03-28: Study NCT03823404; Company role Lead sponsor; Phase Phase 2, Phase 3; Status Completed.
- 2018-03-06: Study NCT03418688; Company role Lead sponsor; Phase Phase 1; Status Completed.
- 2017-12-11: Study NCT03331900; Company role Lead sponsor; Phase Phase 1; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2021-08-26 | NCT04920903 A Single and Multiple Ascending Dose Study of COR588 | Lead sponsor | Phase 1 | Completed | Healthy Volunteers | 64 | 2022-04-30 |
| 2019-03-28 | NCT03823404 GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease | Lead sponsor | Phase 2, Phase 3 | Completed Results posted | Alzheimer Disease | 643 | 2022-01-01 |
| 2018-03-06 | NCT03418688 A Multiple Ascending Dose Study of COR388 | Lead sponsor | Phase 1 | Completed | Alzheimer Disease | 33 | 2018-10-15 |
| 2017-12-11 | NCT03331900 Study of COR388 HCl in Healthy Subjects | Lead sponsor | Phase 1 | Completed | Healthy Subjects | 34 | 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |